Skip to content

Comparison of Postoperative Analgesia Methods in Patients Undergoing Major Intraabdominal Surgery

Comparison of Postoperative Analgesia Methods in Patients Undergoing Major Intraabdominal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06384677
Enrollment
43
Registered
2024-04-25
Start date
2023-04-20
Completion date
2024-02-01
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Cancer, Abdomen Disease

Keywords

major abdominal surgery, M-TAPA, opioid consumption, postoperative analgesia

Brief summary

This study aims to examine the effects of M-TAPA applied for postoperative analgesia in patients who had major intraabdominal surgery on the postoperative pain score, the change in the postoperative total opioid requirement and the side effects.

Detailed description

The investigators seperated the patients into two groups as M-TAPA applied group and control group.In group M-TAPA, M-TAPA block was performed bilaterally with 20 mL of 0.2% bupivacaine under ultrasound guidance at the end of surgery. No block was performed in the control group. The participants were administered morphine through patient controlled analgesia (PCA) pump with a bolus dose of 1 mg, 15 min lockout interval. The postoperative pain scores (the numeric rating scores (NRS)), total opiod consumption in the first 48 h, and opioid related side effects were recorded.

Interventions

M-TAPA block was performed bilaterally with 20 mL of 0.2% bupivacaine under ultrasound guidance at the end of surgery

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* patient \> 17 years old * ASA score 1-3 * undergoing major intra-abdominal surgery

Exclusion criteria

* ASA IV patients * patients with known neurological or psychiatric disorders * patients with clinically significant cardiovascular, respiratory, hepatic, renal or metabolic disease * patients with long-term drug (opioid) or alcohol dependence * patients with BMI\>30 * patients with intellectual disability * patients who developed massive bleeding and coagulopathy

Design outcomes

Primary

MeasureTime frameDescription
Opioid ConsumptionPostoperative 24 hoursThe postoperative opioid consumption

Secondary

MeasureTime frameDescription
NRS Scorespostoperative 24 hoursNumeric Rating Scale score (rating from 1 to 10. 1:no pain to 10: worst pain ever)
the need for rescue analgesiapostoperative 24 hoursif NRS\>4: apply rescue analgesia: the total count of rescue analgesia need
side effectspostoperative 24 hoursnausea- vomiting

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026